These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7721493)

  • 21. On the importance of sympathovagal balance.
    Goldstein B
    Crit Care Med; 2001 Jul; 29(7):1483-4. PubMed ID: 11445718
    [No Abstract]   [Full Text] [Related]  

  • 22. [Cardiovascular effects of ketamine anesthesia in rats treated with enalapril and propranolol].
    Reyes Toso CF; Linares LM; Rodríguez RR
    Medicina (B Aires); 1992; 52(3):240-4. PubMed ID: 1342690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential risk of beta-blockade withdrawal in congestive heart failure due to abrupt autonomic changes.
    Tygesen H; Andersson B; Di Lenarda A; Rundqvist B; Sinagra G; Hjalmarson A; Waagstein F; Wennerblom B
    Int J Cardiol; 1999 Feb; 68(2):171-7. PubMed ID: 10189005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of enalapril treatment on the sensitivity of cardiopulmonary reflexes in rats with myocardial infarction.
    Andrade TU; Pinto VD; Medeiros AR; Abreu GR; Moysés MR; Sampaio KN; Bissoli NS
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):606-11. PubMed ID: 17581216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of enalapril and telmisartan on clinical and biochemical indices of sympathetic activity in hypertensive patients.
    Lewandowski J; Abramczyk P; Dobosiewicz A; Bidiuk J; Sinski M; Gaciong Z
    Clin Exp Hypertens; 2008 Jul; 30(5):423-32. PubMed ID: 18633764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril.
    Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):964-71. PubMed ID: 15803314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac resynchronization therapy restores sympathovagal balance in the failing heart by differential remodeling of cholinergic signaling.
    DeMazumder D; Kass DA; O'Rourke B; Tomaselli GF
    Circ Res; 2015 May; 116(10):1691-9. PubMed ID: 25733594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac vagal activity: a target for intervention in heart disease.
    Townend JN; Littler WA
    Lancet; 1995 Apr; 345(8955):937-8. PubMed ID: 7715289
    [No Abstract]   [Full Text] [Related]  

  • 30. How to study sympatho-vagal balance in arterial hypertension and the effect of antihypertensive drugs?
    Presciuttini B; Duprez D; De Buyzere M; Clement DL
    Acta Cardiol; 1998; 53(3):143-52. PubMed ID: 9793567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure.
    Dibner-Dunlap ME; Smith ML; Kinugawa T; Thames MD
    J Am Coll Cardiol; 1996 Feb; 27(2):358-64. PubMed ID: 8557906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of angiotensin-converting enzyme inhibitor (enalapril or imidapril) on ventilation during exercise in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy.
    Kitaoka H; Takata J; Hitomi N; Furuno T; Seo H; Chikamori T; Doi YL
    Am J Cardiol; 2000 Mar; 85(5):658-60, A10. PubMed ID: 11078286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the replacement of the angiotensin converting enzyme inhibitor enalapril by the angiotensin II receptor blocker telmisartan in patients with congestive heart failure. The replacement of angiotensin converting enzyme inhibition (REPLACE) investigators.
    Dunselman PH;
    Int J Cardiol; 2001 Feb; 77(2-3):131-8; discussion 139-40. PubMed ID: 11182175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enalapril and QTC dispersion in congestive heart failure.
    Brockmeier LB
    Am J Cardiol; 1997 Dec; 80(12):1643. PubMed ID: 9416960
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of cardiac glycosides on spontaneous efferent activity in vagus and sympathetic nerves of cats.
    McLain PL
    Int J Neuropharmacol; 1969 Jul; 8(4):379-87. PubMed ID: 5820455
    [No Abstract]   [Full Text] [Related]  

  • 36. Antiarrhythmic effect of converting enzyme inhibitors in congestive heart failure.
    Gürlek A; Erol C; Basesme E
    Int J Cardiol; 1994 Mar; 43(3):315-8. PubMed ID: 7514156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Status epilepticus produces chronic alterations in cardiac sympathovagal balance.
    Metcalf CS; Radwanski PB; Bealer SL
    Epilepsia; 2009 Apr; 50(4):747-54. PubMed ID: 18727681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enalapril in African patients with congestive cardiac failure.
    Ajayi AA; Balogun MO; Oyewo EA; Ladipo GO
    Br J Clin Pharmacol; 1989 Mar; 27(3):400-3. PubMed ID: 2541754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of enalapril on different aspects of the clinical state in congestive heart failure.
    Dargie HJ
    Drugs; 1986; 32 Suppl 5():45-9. PubMed ID: 3032563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of angiotensin converting enzyme inhibition on pump function and cardiac contractility in patients with chronic congestive heart failure.
    Baur LH; Schipperheyn JJ; Baan J; van der Laarse A; Buis B; van der Wall EE; Manger Cats V; van Dijk AD; Blokland JA; Frölich M
    Br Heart J; 1991 Mar; 65(3):137-42. PubMed ID: 2015121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.